Health Absorbed | Longevity Science Series

The Sixteen Hallmarks
of Aging

An original expansion of the López-Otín framework — the most comprehensive single-chapter treatment of aging biology currently available, with full evidence grading and clinical intervention mapping.

16 HallmarksOriginal Framework
Beyond Cell 2023+4 New Hallmarks
VancouverCitations
A–D GradingThroughout
GlycanAgeIgG Glycan Biomarker
scroll

Document Structure

Section 1
Introduction and Framework Evolution
From 9 to 12 to 16 hallmarks — the history and rationale
Section 2
Primary Hallmarks (H1–H5)
Fundamental causes of cellular damage — genomic, telomeric, epigenetic, proteostatic, RNA
Section 3
Antagonistic Hallmarks (H6–H9)
Protective systems that become pathological — autophagy, nutrient sensing, mitochondria, senescence
Section 4
Integrative Hallmarks (H10–H16)
Systemic downstream consequences — allostatic load, stem cells, inflammaging, dysbiosis, ECM, psychosocial
Section 5
Sleep, Nutrition, and Exercise Across All 16
Master reference table mapping lifestyle interventions to each hallmark with evidence grades
Section 6
Pharmacological Interventions
Senolytics, rapamycin, NAD⁺ precursors, metformin — current trial evidence reviewed
Section 7
Epigenetic Age Clocks
GrimAge, PhenoAge, DunedinPACE — derivation, interpretation, and intervention evidence
Section 8
Clinical Takeaways and Synthesis
Five key messages for practitioners; the convergence toward biological age reversal
01
Introduction

The Hallmarks Framework: Evolution and Rationale

From nine to twelve to sixteen — the expanding universe of aging biology

Overview

The hallmarks of aging represent one of the most influential conceptual frameworks in modern gerontology — first proposed by López-Otín, Blasco, Partridge, Serrano, and Kroemer in their landmark 2013 Cell paper, identifying nine fundamental processes characterising aging across species.[1] In 2023, the same authors published an expanded framework of twelve hallmarks.[2] This document expands the framework to sixteen hallmarks, incorporating four additional processes that meet all three required criteria: age-association, experimental acceleration of aging on induction, and therapeutic modifiability.

2013
Original 9-hallmark Cell paper
2023
Expanded to 12 hallmarks
16
Hallmarks in this framework
+4
Original additions beyond Cell 2023

The Four Additional Hallmarks

The four hallmarks added beyond the Cell 2023 framework each meet the three mechanistic criteria and reflect evidence that aging cannot be fully understood through cellular mechanisms alone — systemic stress responses, tissue mechanics, and mind-body connections play fundamental biological roles.

Original Additions to the Framework

H5 — RNA Processing Dysregulation: Spliceosome dysfunction and CHIP produce pervasive transcriptomic errors that compound proteostasis failure. H10 — Cellular Allostatic Load: Chronic HPA axis dysregulation constitutes a mechanistically established integrative hallmark through cortisol-mediated damage across multiple systems. H15 — ECM Changes: Extracellular matrix glycation, AGE crosslink accumulation, and MMP dysregulation drive tissue stiffening with measurable cardiovascular and musculoskeletal consequences. H16 — Psychosocial Factors: Social isolation and loss of purpose activate aging pathways through the CTRA mechanism, HPA dysregulation, and telomere biology — with epidemiological equivalence to smoking as a mortality risk factor.

Three-Tier Hierarchy

The sixteen hallmarks are organised into three tiers. Primary hallmarks (H1–H5) are the fundamental sources of biological damage — processes occurring throughout life whose repair becomes insufficient with age. Antagonistic hallmarks (H6–H9) represent the failure modes of systems that evolved to be protective — becoming pathological when they can no longer be adequately regulated. Integrative hallmarks (H10–H16) describe how molecular and cellular dysfunction manifests at the systemic level, completing the picture of the aging network.[1,2]

hallmarks of agingLópez-OtínCell 2023aging frameworkgerontologylongevity medicinebiological ageCTRAallostatic load
02
Primary Hallmarks

Primary Hallmarks — H1 to H5

The fundamental sources of cellular damage from which aging emerges

Tier Definition

Primary hallmarks represent processes that occur even in optimal conditions but whose repair becomes insufficient with age. DNA lesions accumulate at 10,000–100,000 per cell per day; telomeres shorten with each cell division; epigenetic marks drift from youthful patterns; proteins misfold as chaperone capacity declines; and RNA splicing errors increase as spliceosome machinery deteriorates. None are truly age-specific — all occur throughout life — but the balance between damage generation and repair shifts inexorably with time.

H1
Genomic Instability
Primary Hallmark
DNA damage accumulates at 10,000–100,000 lesions per cell per day. Repair systems — base excision repair, nucleotide excision repair, and homologous recombination — decline in efficiency with age. Unrepaired lesions produce mutations, chromosomal rearrangements, and transcriptional errors. Biomarker: 8-oxo-dG (oxidative DNA damage) and γH2AX foci (double-strand breaks). Key interventions: sleep (DNA repair is circadian-regulated and peaks during slow-wave sleep), exercise (Grade A), antioxidant nutrition, NAD⁺ repletion.[3,4]
H2
Telomere Attrition
Primary Hallmark
Telomeres — repetitive TTAGGG sequences capping chromosome ends — shorten with each somatic cell division and are additionally attacked by oxidative stress. Critically short telomeres trigger the DNA damage response, producing replicative senescence (Hallmark 9) or apoptosis. Chronic psychological stress accelerates telomere attrition through HPA-axis-mediated oxidative damage — a key mechanistic link between psychosocial adversity and accelerated biological aging.[5,6] Exercise (Grade A), Mediterranean diet (Grade B), and chronic stress reduction (Grade A) are the strongest evidence-based interventions.
H3
Epigenetic Alterations
Primary Hallmark
DNA methylation patterns drift from youthful configurations with age — some CpG sites gain methylation (silencing tumour suppressors and developmental genes), others lose it (de-repressing transposable elements and inflammatory genes). Histone modification patterns also shift, altering chromatin accessibility and gene expression. The epigenetic clock algorithms — Horvath (353 CpGs), PhenoAge (513 CpGs), GrimAge (∼1,000 CpGs), and DunedinPACE (pace of aging) — are derived from these methylation changes and now constitute the gold standard for biological age measurement. PTSD has been shown to accelerate epigenetic age by 3–7 years through HPA-driven methylation drift.[7,8]
H4
Loss of Proteostasis
Primary Hallmark
The proteostasis network — encompassing molecular chaperones (HSP70, HSP90), the ubiquitin-proteasome system (UPS), and macroautophagy — maintains protein folding fidelity and clears misfolded or damaged proteins. Age-related decline in each component allows misfolded proteins to accumulate, forming the toxic aggregates characteristic of neurodegeneration: amyloid-β and tau (Alzheimer's), α-synuclein (Parkinson's), SOD1 and TDP-43 (ALS). The glymphatic system — the brain's waste clearance system, active exclusively during slow-wave sleep — provides the primary clearance route for CNS protein aggregates, making sleep the single most important proteostasis intervention for neurological aging.[9,10]
H5
RNA Processing Dysregulation
Primary Hallmark — Original Addition
Spliceosome machinery accumulates damage with age, producing widespread alternative splicing errors that generate dysfunctional protein isoforms — a largely hidden layer of proteome deterioration that compounds direct protein misfolding (H4). CHIP (clonal haematopoiesis of indeterminate potential) — somatic mutations in spliceosome genes (SF3B1) and epigenetic regulators (DNMT3A, TET2, ASXL1) — affects more than 10% of adults over 70 and confers significantly elevated cardiovascular and haematological malignancy risk independent of other risk factors.[11,12]
genomic instabilitytelomere attritionepigenetic clockproteostasisglymphatic systemCHIPspliceosomeamyloidDNA repair8-oxo-dG
03
Antagonistic Hallmarks

Antagonistic Hallmarks — H6 to H9

Protective systems that evolved for survival but become pathological with age

Tier Definition

Antagonistic hallmarks occupy a uniquely important position in the aging network because they represent the failure modes of systems that evolved to be protective. Autophagy (cellular recycling) becomes overwhelmed. The nutrient-sensing network that evolved to alternate between growth and maintenance becomes chronically locked in the growth state in sedentary, overnourished modern populations. Mitochondria progressively produce more reactive oxygen species and less ATP. Cellular senescence — originally an anti-cancer mechanism — becomes pathological when senescent cells accumulate and secrete the pro-aging SASP.

H6
Disabled Macroautophagy
Antagonistic Hallmark
Autophagy — the lysosomal degradation pathway clearing damaged organelles, protein aggregates, and intracellular pathogens — declines with age through mTOR hyperactivation, Beclin-1 downregulation, and reduced TFEB nuclear translocation. Declining autophagy allows the accumulation of dysfunctional mitochondria (mitophagy failure), protein aggregates (chapersome-mediated autophagy failure), and lipid droplets (lipophagy failure) — directly compounding Hallmarks 3, 4, and 8. Time-restricted eating (14–16 hours daily fast) is the strongest lifestyle stimulus for autophagy induction, acting through AMPK activation and mTOR suppression. Spermidine (naturally occurring polyamine found in wheat germ, aged cheese, and mushrooms) directly induces autophagy and is the most evidence-supported dietary supplement for this hallmark.[13,14]
H7
Deregulated Nutrient Sensing
Antagonistic Hallmark
The nutrient-sensing network — comprising the insulin/IGF-1 signalling (IIS) axis, mTOR complex 1, AMPK, and the sirtuin family — evolved to oscillate between anabolic (fed, growth) and catabolic (fasted, repair) states. Chronic overnutrition and sedentarism produce persistent IIS and mTOR activation with reciprocal suppression of AMPK and SIRT1 — locking cells in the growth state and preventing the autophagy, stress resistance, and DNA repair that the catabolic state enables. This is the central mechanism linking the modern dietary and activity environment to accelerated biological aging. Caloric restriction (Grade A for lifespan extension across species), time-restricted eating, metformin, and exercise all act primarily through this hallmark.[15,16]
H8
Mitochondrial Dysfunction
Antagonistic Hallmark
Mitochondria — generating 90–95% of cellular ATP through oxidative phosphorylation — progressively deteriorate with age through ETC complex damage, mtDNA mutation accumulation, NAD⁺ depletion (reducing SIRT3 and SIRT1 activity), and declining mitophagy (the selective autophagy that clears dysfunctional mitochondria). Dysfunctional mitochondria produce elevated ROS with reduced ATP — a catastrophic energy-crisis-plus-oxidative-stress combination. VO₂max is the clinical biomarker of mitochondrial capacity; its decline of approximately 10% per decade after age 30 directly tracks mitochondrial deterioration. HIIT is the most potent stimulus for mitochondrial biogenesis via PGC-1α upregulation, with NR and NMN supplementation addressing the upstream NAD⁺ depletion.[17,18]
H9
Cellular Senescence
Antagonistic Hallmark
Cellular senescence — permanent cell cycle arrest triggered by oncogenic stress, DNA damage, oxidative stress, and telomere dysfunction — evolved as a tumour-suppressive mechanism. Senescent cells develop the senescence-associated secretory phenotype (SASP): a complex secretome of 80+ pro-inflammatory cytokines, MMPs, and growth factors that drive local and systemic inflammation, paracrine senescence, and tissue remodelling. Senescent cells accumulate with age because immune clearance (immunosenescence) fails to remove them at the rate they form. Senolytics — led by Dasatinib plus Quercetin and Fisetin — selectively eliminate senescent cells by targeting their anti-apoptotic survival pathways; Phase 1/2 trials in idiopathic pulmonary fibrosis, diabetic kidney disease, and Alzheimer's disease show promising biomarker and functional improvements.[19,20]
autophagymTORAMPKSIRT1nutrient sensingmitochondriaNAD⁺PGC-1αSASPsenolyticsDasatinib QuercetinFisetin
04
Integrative Hallmarks

Integrative Hallmarks — H10 to H16

How molecular and cellular dysfunction manifests at the systemic level

Tier Definition

Integrative hallmarks complete the framework by describing the systemic consequences of primary and antagonistic hallmark progression. Individually, each integrative hallmark is a downstream amplifier; collectively, they constitute the observable phenotype of aging — frailty, cognitive decline, metabolic disease, immune senescence, and loss of resilience.

H10
Cellular Allostatic Load
Integrative — Original Addition
Allostatic load quantifies the cumulative physiological burden of chronic stress system activation. Persistent HPA axis stimulation produces glucocorticoid receptor resistance, elevated basal cortisol, disrupted diurnal cortisol rhythm, autonomic imbalance (reduced HRV), and chronic low-grade inflammation. These changes independently accelerate H2 (telomere attrition), H3 (epigenetic aging), H8 (mitochondrial dysfunction), and H13 (inflammaging). HRV is the most accessible clinical biomarker. Mindfulness-based stress reduction (MBSR, Grade A), structured exercise, social connection, and sleep optimisation are the primary interventions.[21]
H11
Stem Cell Exhaustion
Integrative Hallmark
Tissue-resident stem cell populations — haematopoietic, muscle satellite cells, neural progenitors, intestinal crypts — decline in number and function with age through intrinsic mechanisms (accumulated DNA damage, epigenetic drift, mitochondrial decline) and niche deterioration (SASP-driven inflammatory niche, declining systemic growth factors). Stem cell exhaustion explains why damaged tissues regenerate progressively less effectively with age — the regenerative reserve fails. Exercise preserves satellite cell number and function in skeletal muscle (Grade A); adequate protein intake (≥1.6 g/kg/day) supports anabolic signalling required for muscle stem cell activation.[22]
H12
Altered Intercellular Communication
Integrative Hallmark
Ageing profoundly alters the signals cells send to one another — through declining endocrine axes (testosterone, oestrogen, IGF-1, GH), the replacement of normal paracrine signalling by SASP inflammatory mediators, and shifts in exosome cargo from regenerative to inflammatory microRNA profiles. The heterochronic parabiosis paradigm — in which young plasma factors (GDF11, VEGF, TIMP2) partially rejuvenate aged tissues when systemically administered — directly demonstrates that intercellular communication is a tractable aging target. HRT where clinically indicated (Grade B) and exercise-driven GH pulsatility restoration are among the evidence-based interventions.[23]
H13
Chronic Inflammation — Inflammaging
Integrative Hallmark
Inflammaging — the chronic, sterile, low-grade inflammatory state characteristic of aging — is the universal background against which all age-related disease develops. Its sources include SASP from accumulating senescent cells (H9), metabolic endotoxemia from gut dysbiosis (H14), mitochondrial DAMP release (H8), adipose tissue macrophage infiltration, and loss of immunoregulatory T cell function. Biomarkers: hsCRP, IL-6, TNF-α, GDF15. The Mediterranean dietary pattern (Grade A), regular exercise (Grade A), sleep optimisation (Grade A), and omega-3 supplementation (Grade B) are the most potent evidence-based anti-inflammaging interventions.[24,25]
H14
Dysbiosis
Integrative Hallmark
The gut microbiome undergoes systematic compositional changes with aging — reduced microbial diversity, loss of beneficial butyrate-producing Firmicutes (Faecalibacterium prausnitzii, Roseburia), and expansion of pro-inflammatory Proteobacteria. Reduced butyrate production impairs intestinal barrier integrity, increasing lipopolysaccharide (LPS) translocation into systemic circulation — directly fuelling H13 inflammaging. The Mediterranean diet (30g+ daily dietary fibre, fermented foods) is the most robustly evidence-based microbiome intervention, with demonstrated effects on microbiome diversity and reduction of systemic LPS levels.[26]
H15
Extracellular Matrix Changes
Integrative — Original Addition
The ECM — the structural scaffold of every tissue — undergoes progressive glycation and AGE (advanced glycation end-product) crosslink accumulation, MMP dysregulation, and collagen and elastin fragmentation with age. These changes produce the tissue stiffening that underlies arterial aging (measured by pulse wave velocity — the gold-standard ECM biomarker for the cardiovascular system), osteoarthritis, organ fibrosis, and skin aging. Exercise preserves arterial compliance through endothelial shear stress stimulation of eNOS and MMP remodelling. Glycaemic control reduces the rate of new AGE crosslink formation.[27]
H16
Psychosocial Factors
Integrative — Original Addition
The inclusion of psychosocial factors as a biological hallmark — not a soft correlate — is mechanistically justified through three converging pathways. The Conserved Transcriptional Response to Adversity (CTRA) produces stereotyped pro-inflammatory NF-κB upregulation and antiviral response downregulation in response to social threat, measurable at the gene expression level. Chronic loneliness predicts all-cause mortality with the statistical power of smoking — through inflammatory, neuroendocrine, and behavioural pathways. Purpose in life independently predicts Alzheimer's disease risk, dementia incidence, and all-cause mortality through neurobiological mechanisms including hippocampal neurotrophin expression. Social engagement, meaningful occupation, and MBSR are Grade A interventions for this hallmark.[28,29]
inflammagingdysbiosisstem cell exhaustionallostatic loadECM changesAGE crosslinksCTRAloneliness mortalitypurpose in lifeHRVSASP
05
Lifestyle Interventions

Sleep, Nutrition, and Exercise Across All 16 Hallmarks

The three lifestyle pillars mapped to each hallmark with specific mechanisms and evidence grades

The Universal Foundation

Sleep optimisation (7–9 hours), a Mediterranean dietary pattern with ≥30g daily fibre, and regular exercise (150+ minutes moderate aerobic plus two resistance sessions weekly) collectively address 14–16 of the sixteen hallmarks simultaneously — producing effect sizes that no current pharmacological intervention can match safely. These are not lifestyle suggestions. They are pharmaceutical-grade biological interventions with mechanistic justification at the molecular level and Grade A evidence across each hallmark.[30]

#HallmarkSleep MechanismNutrition MechanismExercise MechanismGrade
H1Genomic InstabilityDNA repair enzymes circadian-regulated; peak activity in slow-wave sleepFolate, B12, antioxidants support repairExercise induces DNA repair via ATM activationA
H2Telomere AttritionDeprivation accelerates attrition via oxidative stressMediterranean diet reduces attrition rateAerobic exercise — strongest lifestyle intervention for telomere preservationA
H3Epigenetic AlterationsCircadian methylation maintenance; disruption accelerates clockMethyl donors (folate, choline) essential; caloric restriction slows clockExercise decelerates GrimAge and DunedinPACEA
H4Loss of ProteostasisGlymphatic clearance exclusively during slow-wave sleepFasting induces all autophagy types; Mediterranean diet reduces protein aggregationExercise induces heat shock proteins; activates autophagyA
H5RNA ProcessingCircadian regulation of 3,000+ splice events disrupted by poor sleepB vitamins support RNA methylationExercise reduces CHIP expansion risk via anti-inflammatory effectsB
H6Disabled AutophagyFasting window during sleep activates autophagy via AMPKTime-restricted eating (14–16h fast) is the primary autophagy stimulusExercise activates AMPK, suppresses mTOR, induces autophagyA
H7Nutrient SensingPoor sleep produces insulin resistance within 3 nightsCaloric restriction, TRE, ketogenic diet reduce IIS and mTOR signallingExercise activates AMPK and SIRT1 — the most potent lifestyle nutrient-sensing interventionA
H8Mitochondrial DysfunctionMitochondrial biogenesis occurs during deep sleep via GH/IGF-1Mediterranean diet provides polyphenols (mitochondrial uncouplers); omega-3 supports membrane integrityHIIT is the gold standard stimulus for mitochondrial biogenesis via PGC-1αA
H9Cellular SenescenceSleep deprivation accelerates senescence; adequate sleep maintains immune clearanceCaloric restriction reduces senescence rate; Mediterranean pattern reduces SASPExercise reduces senescent cell burden and maintains NK cell clearance capacityA
H10Allostatic LoadThe primary allostatic load recovery mechanism — cortisol normalisation occurs during sleepMediterranean diet reduces HPA reactivity; omega-3 reduces cortisol responseExercise is the most evidence-based intervention for HPA axis normalisationA
H11Stem Cell ExhaustionGH secretion (satellite cell activation) peaks in slow-wave sleepProtein ≥1.6g/kg/day supports muscle satellite cell activationResistance training directly activates muscle satellite cellsA
H12Intercellular CommunicationGH and testosterone pulsatility restored by adequate sleepZinc, vitamin D support testosterone and IGF-1 productionExercise restores anabolic hormone pulsatility and reduces inflammatory secretomeB
H13InflammagingSleep deprivation raises IL-6 and CRP; adequate sleep is anti-inflammatoryMediterranean diet — strongest evidence base for systemic inflammation reductionRegular exercise reduces hsCRP, IL-6, and TNF-α (Grade A)A
H14DysbiosisCircadian rhythm maintains gut microbiome diversity; disruption promotes dysbiosis30g+ dietary fibre daily; fermented foods — primary microbiome interventionsExercise independently increases microbiome diversity and butyrate producersA
H15ECM ChangesCollagen synthesis peaks during sleep via GHGlycaemic control reduces new AGE formation; vitamin C supports collagen synthesisExercise reduces PWV (arterial stiffness) via eNOS activationA
H16Psychosocial FactorsSleep is the foundation of emotional regulation and stress resilienceMediterranean diet reduces depression risk and cortisol reactivityExercise produces BDNF, reduces loneliness impact on mortality, and is Grade A for depressionA
Mediterranean diettime-restricted eatingHIITresistance trainingsleep optimisationglymphatic clearancePGC-1αAMPKcaloric restrictionketogenic diet
06
Pharmacology

Pharmacological Interventions in Longevity Medicine

Senolytics, mTOR inhibitors, NAD⁺ precursors, and metformin — evidence reviewed

Evidence Caveat

Senolytics, mTOR inhibitors, and NAD⁺ precursors have genuine clinical promise supported by early trial data, but none have completed the long-term safety and efficacy trials required for evidence-based recommendation outside of clinical trial contexts. The interventions below are presented as emerging rather than established treatments. Prescribing in clinical practice requires transparent discussion of experimental status.

Senolytics — Dasatinib, Quercetin, Fisetin

Senescent cells develop anti-apoptotic survival mechanisms — upregulating BCL-2, BCL-XL, PI3K/AKT/mTOR, and HSP90 — to resist the cell death their own SASP would normally trigger. Senolytics exploit this vulnerability by selectively inhibiting these pro-survival pathways in senescent cells while sparing normal cells. Dasatinib (SRC/BCR-ABL kinase inhibitor) combined with Quercetin (BCL-2 and PI3K inhibitor) has completed Phase 1/2 trials in idiopathic pulmonary fibrosis, diabetic kidney disease, Alzheimer's disease, and COVID-19-related lung disease — demonstrating reductions in circulating senescence biomarkers (p16, p21, IL-6, MMP-9) and improvements in functional outcomes including 6-minute walk test. Fisetin (Grade A in animal models, Phase 2 in humans) offers a potentially safer alternative with similar BCL-2 inhibitory activity.[19,20]

Rapamycin and Rapalogs

Rapamycin (mTOR complex 1 inhibitor) is the most reproducible longevity-extending pharmacological intervention across species — from yeast and nematodes through mice, where late-life initiation extends median lifespan by 9–14%. The PEARL human trial demonstrated that low-dose intermittent rapamycin (5 mg/day for two weeks on, four weeks off) reduced biological aging markers and improved immune function in healthy older adults with manageable side effects. Everolimus (oral rapalog) improved influenza vaccine response in elderly subjects in the TRITON trial — the first clinical evidence that mTOR inhibition restores age-related immune decline in humans. The clinical challenge remains separating the efficacy signal (mTOR suppression in aged tissue) from immunosuppressive toxicity.[31,32]

NAD⁺ Precursors — NR and NMN

NAD⁺ declines by 40–60% between young adulthood and age 60–70, reducing SIRT1, SIRT3, and PARP1 activity — enzymes central to DNA repair (H1), mitochondrial function (H8), and nutrient sensing (H7). Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) raise blood NAD⁺ concentrations in human trials, with promising signals for muscle mitochondrial function, inflammatory reduction, and cognitive performance. Long-term efficacy and safety data in humans remain pending from ongoing trials. Current evidence supports NR and NMN as reasonably safe NAD⁺ repletion strategies with plausible mechanistic benefit, but without the long-term human trial data to confirm clinical efficacy.[33]

Metformin — The TAME Trial

Metformin (AMPK activator, mTOR suppressor) has long been observed to produce apparent health benefits beyond glucose control in type 2 diabetic populations — including reduced cancer incidence, cardiovascular events, and all-cause mortality compared with other anti-diabetic agents. The landmark TAME (Targeting Aging with Metformin) trial is the first trial designed to test whether a drug can receive FDA approval for the indication of slowing biological aging rather than treating a specific disease — a regulatory paradigm shift that, if successful, would transform longevity pharmacology.[34]

senolyticsDasatinib QuercetinFisetinrapamycinPEARL trialmTOR inhibitionNR NMNNAD⁺metforminTAME trialSIRT1
07
Epigenetic Clocks

Epigenetic Age Clocks

GrimAge, PhenoAge, DunedinPACE — measuring biological age and the pace of aging

Why Clocks Matter

Chronological age is a poor proxy for biological age. Two 65-year-olds may have biological ages of 55 and 75 respectively — with dramatically different disease risk profiles, functional capacities, and remaining healthspans. Epigenetic clocks, derived from DNA methylation patterns at specific CpG sites, provide an objective, blood-test-accessible measure of biological age that predicts mortality, disease risk, and functional capacity better than chronological age alone in most population studies.

The Principal Clocks

The Horvath multi-tissue clock (353 CpGs, 2013) was the foundational epigenetic age predictor — highly accurate across tissues but less sensitive to disease and lifestyle variation. PhenoAge (513 CpGs, 2018) was trained on clinical phenotypic data and correlates more strongly with physical function, inflammation, and mortality than Horvath. GrimAge (~1,000 CpGs, 2019) is trained on time-to-death and is the strongest current predictor of morbidity and mortality — with GrimAge acceleration of five or more years conferring substantially elevated risk of cardiovascular disease, cancer, and all-cause mortality.[7,8]

DunedinPACE — Measuring the Rate of Aging

DunedinPACE differs fundamentally from all earlier clocks. Rather than estimating biological age as a single number, it measures the pace of aging — the rate of biological deterioration per unit chronological time — calibrated against longitudinal biomarker change data from the Dunedin Study cohort. A DunedinPACE of 1.0 represents average aging; values above 1.0 indicate faster-than-average biological aging; below 1.0 indicates slower aging. Its key advantage for intervention research is sensitivity to change over months rather than years — making it the preferred outcome measure in longevity trials. The CALERIE caloric restriction trial used DunedinPACE to demonstrate — for the first time in a randomised controlled trial — that biological aging rate is measurably modifiable in living humans through a 25% caloric restriction intervention over two years.[35]

"The convergence of multi-hallmark biological understanding with precision measurement tools and targeted therapeutics positions the 2020s–2030s as the period when longevity medicine transitions from evidence-based prevention to evidence-based biological age reversal."

The Sixteen Hallmarks of Aging — Section 4.9

7.3 GlycanAge — Measuring Inflammaging Directly

While epigenetic clocks measure biological age through DNA methylation patterns, GlycanAge takes a fundamentally different approach — measuring the pattern of N-glycans attached to immunoglobulin G (IgG) antibodies in circulating blood. Glycans are complex sugar molecules that are enzymatically added to IgG at specific sites, and their composition directly regulates the inflammatory potential of the immune system. The GlycanAge test is grounded in more than 30 years of glycoscience research and over 350 peer-reviewed publications, constituting one of the most extensively validated commercial biological age biomarkers currently available.[36,37]

The Science of IgG Glycosylation

IgG glycans are not passive bystanders — they actively determine whether IgG antibodies promote or suppress inflammation. Anti-inflammatory IgG carries high levels of galactosylation and sialylation on its Fc domain, which dampen complement activation and ADCC. With age, and with poor lifestyle, galactosylation and sialylation decline while agalactosylated and bisecting N-acetylglucosamine (GlcNAc) structures increase — producing IgG with elevated pro-inflammatory capacity. This glycan shift both reflects and causally drives inflammaging (Hallmark 13), creating a measurable molecular signature of the chronic inflammatory state of aging.[38]

7.3.1 Predictive Power Relative to Other Biomarkers

A landmark study analysing IgG glycosylation in 5,117 individuals across four European populations demonstrated that a combined index of three IgG glycans — FA2B, FA2G2, and FA2BG2 — explained up to 58% of the variance in chronological age.[36] This substantially exceeds the predictive power of telomere length, which accounts for only 15–25% of age variance in most studies. After correcting for chronological age, the GlycanAge index correlated strongly with physiological parameters associated with biological age, confirming that IgG glycosylation reflects not merely the passage of time but the underlying rate of biological deterioration. The key distinction between GlycanAge and epigenetic clocks is biological: GlycanAge measures the inflammatory arm of the aging process specifically, providing a direct readout of Hallmark 13 (inflammaging) that complements the broader biological age information provided by GrimAge and DunedinPACE.

7.3.2 GlycanAge and Exercise — Peer-Reviewed Evidence

The relationship between exercise and GlycanAge is of direct relevance to exercise practitioners. A peer-reviewed study published in Glycoconjugate Journal examined GlycanAge across professional athletes, regularly moderately active individuals, newly recruited recreational exercisers, and inactive controls. The primary finding was that regularly moderately active individuals had a GlycanAge 7.4 years lower than inactive controls — one of the largest lifestyle-associated biological age differences recorded for any single biomarker.[39] Importantly, professional athletes showed a nominally higher GlycanAge than regularly moderate exercisers, consistent with the J-curve hypothesis of exercise and immune function: moderate sustained training optimally shifts IgG glycans toward an anti-inflammatory profile, while extreme exercise volumes may paradoxically shift the glycan profile toward pro-inflammation through chronic physiological stress.[39]

Direct Relevance to This Framework

The exercise dose that produces optimal GlycanAge reduction — regular moderate activity sustained consistently over years — precisely matches the exercise prescription for all other inflammatory hallmarks in this document. This convergence is not coincidental; it reflects the same underlying biology. For individuals using GlycanAge as a monitoring tool, the Health Absorbed exercise framework — five sessions per week, combining resistance and aerobic modalities at moderate-to-vigorous intensity — represents the type of programme demonstrated to produce the greatest anti-inflammatory glycan benefit in peer-reviewed evidence.

7.3.3 Modifiability by Dietary and Metabolic Interventions

GlycanAge is distinguished from some other biological age biomarkers by its demonstrated responsiveness to lifestyle intervention over relatively short timeframes. Published studies confirm that GlycanAge can be meaningfully reduced by dietary pattern change, weight loss, and caloric restriction. A study of bariatric surgery candidates demonstrated significant shifts in IgG N-glycan composition following substantial weight loss.[40] A pilot study examining two-year caloric restriction in the context of glycomic biological age found that caloric restriction may reduce GlycanAge biomarker indices, consistent with the CALERIE trial's DunedinPACE findings.[41] The responsiveness of IgG glycans to Mediterranean dietary patterns — through their anti-inflammatory effects on SASP, gut dysbiosis, and adipose tissue inflammation — makes GlycanAge a practical monitoring tool for combined diet-and-exercise longevity interventions.

7.3.4 Clinical Accessibility

A practical advantage of GlycanAge over epigenetic clocks is its accessibility. The test requires only a finger-prick blood sample sent by post to a specialist laboratory, with results typically returned within two to three weeks alongside personalised interpretation of the inflammatory glycan profile and recommendations for lifestyle optimisation. This accessibility, combined with its sensitivity to lifestyle change over months rather than decades, makes GlycanAge among the most practically useful biological age monitoring tools for exercise practitioners, health coaches, and motivated individuals implementing the longevity protocols described in this framework. GlycanAge is best understood as a complementary biomarker to epigenetic clocks rather than a replacement: DunedinPACE measures the overall pace of biological aging; GrimAge predicts time-to-death; GlycanAge specifically quantifies the inflammatory glycan dimension of aging — an aspect of biology that is particularly responsive to the exercise and dietary interventions that constitute the core of evidence-based longevity practice.

epigenetic clockGrimAgePhenoAgeDunedinPACEHorvath clockbiological ageDNA methylationGlycanAgeIgG glycosylationinflammaging biomarkerN-glycansgalactosylationCALERIE trialpace of aging
08
Clinical Synthesis

Five Clinical Takeaways for Practitioners

What the sixteen-hallmark framework means for evidence-based longevity practice

01
Measure Biological, Not Just Chronological Age
Epigenetic clocks (GrimAge, DunedinPACE), CHIP panels, inflammatory composite indices, arterial stiffness (PWV), and microbiome analyses now enable biological age assessment beyond chronological age. These tools should become as standard as lipid panels and blood pressure in longevity-focused practice.
02
The Universal Interventions Are Non-Negotiable
Exercise, Mediterranean diet, sleep optimisation, and stress management address 14–16 hallmarks simultaneously. Any longevity protocol lacking these elements is fundamentally incomplete. These interventions produce effect sizes that no current pharmacological intervention can match safely, and they are synergistic rather than additive.
03
Pharmacology Is Emerging, Not Established
Senolytics, mTOR inhibitors, and NAD⁺ precursors have genuine promise supported by early trial data. None have completed the long-term safety and efficacy trials required for evidence-based recommendation outside clinical trial contexts. Transparent discussion of experimental status is mandatory when considering these agents.
04
Psychosocial Factors Are Biological Factors
Social isolation, loneliness, and loss of purpose activate aging pathways through the CTRA mechanism, HPA dysregulation, and telomere biology — with epidemiological mortality equivalence to smoking. Longevity medicine must address social health with the same rigour as cardiovascular health or metabolic function.
05
The Field Is Moving Faster Than Any Textbook Can Capture
Partial reprogramming, plasma proteomics, single-cell transcriptomics of aging, targeted senolytic development, and microbiome engineering are advancing rapidly. Practitioners in longevity medicine must engage with primary literature and clinical trial registries to remain current. The hallmarks framework presented here, while representing the best current synthesis, will continue evolving.
longevity medicinebiological age reversalpartial reprogrammingYamanaka factorsheterochronic parabiosisprecision longevitymorbidity compressionhealthspanlifespan extension
Framework Synthesis

Six Principles of the Sixteen-Hallmark Framework

Principle 01
Aging Is a Modifiable Network State

Aging is not an immutable biological program. It is an emergent property of at least sixteen interacting mechanisms — each of which is now a legitimate therapeutic target.

Principle 02
Lifestyle Addresses the Most Hallmarks Simultaneously

Sleep, Mediterranean diet, and exercise collectively address 14–16 hallmarks with Grade A evidence — no pharmacological intervention comes close to this breadth of effect.

Principle 03
Measure Biological Age, Not Just Chronological Age

Epigenetic clocks, PWV, grip strength, and inflammatory panels now make biological age assessment accessible. What gets measured gets managed.

Principle 04
Psychosocial Factors Are Biologically Real

Loneliness kills through molecular mechanisms. Purpose in life protects through neurobiological pathways. Social health is biological health.

Principle 05
Pharmacology Is Approaching, Not Yet Arrived

Senolytics, rapamycin, and NAD⁺ precursors show genuine promise. But they complement — not replace — the lifestyle foundation, and their evidence base is still maturing.

Principle 06
Biological Age Reversal Is No Longer Theoretical

The CALERIE trial proved that biological aging pace is modifiable in living humans. The DunedinPACE clock can measure the response. The 2030s may see the first clinical confirmation of biological age reversal.